Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by Tulsa123 on Jun 10, 2024 7:52pm

Interesting

How this stock for many years became unnoticed not respected and dull. I am uncomfortable to buy more shares when their is no heartbeat. What a great discovery and TLT are you for real. Glta
Comment by beenthere on Jun 10, 2024 8:10pm
Hard to make sense of this for sure! I have a small position from many years ago of the common. And I have 30000 shares of the warrants which looks like it's worth zero! I really don't follow this continuously but in my imo and this is my imo ( don't expect to see any likes of this post) There is a group of investors here ( a really large group of investors) who fell in love with ...more  
Comment by charlierock on Jun 10, 2024 9:19pm
Yes don't fall in love with a stock and if it's not working cut your losses. However in TLT's case it is working, better than anything else out there with many other cancer indications on the horizon not to mention very promising early results on the virus research. When BTD comes the stock price will follow.
Comment by CancerSlayer on Jun 11, 2024 12:13am
Yep...always wise to date the share price before marrying the investment.  This particular one was a keeper imo. The latest news, while highlighting the achievement of yet another promising preclinical milestone, may ultimately allow us to get a bigger foot in the door of Big Pharma as TLT's tech marries Merck's.  Intimately connecting to a standard of care (i.e. Big Pharma) is ...more  
Comment by Oilminerdeluxe on Jun 11, 2024 2:50am
The AGM, there should be plenty to talk about for those attending if Roger is up to it that is. Three really good news releases in short order. I suspect financing is next. If I were to bet, another small one, but it is better to have some money than none at all. We will see. That BTD is at least within grasp. No more delays, please. Having trials for GBM and Lung would be truly epic. 2025 could ...more  
Comment by managementfirst on Jun 11, 2024 6:20am
BTD is really took too long. Since last year July pre-apllication, one year already passed. if Roger keep delaying, a lot of warrants will expire,not only common share holders, himself also get badly damaged.
Comment by CAinPlap on Jun 11, 2024 9:51am
First the wedding, then the divorce where we take half their market cap. lol
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250